TABLE 3.
Characteristics of participants at 12 months by group
| All participants N = 204 | CON group N = 106 | INT group (N = 98) | ||
|---|---|---|---|---|
| N (valid %) | N (%) | N (%) | N (%) | P-value (group difference)a |
| Child health | ||||
| Characteristics at 12 months | ||||
| Symptom free days/past 2 weeks | 8.5 d (5.4) | 9.2 d (5.1) | 7.8 d (5.7) | 0.06 |
| Symptom free nights/past month | 23.9 n (9.5) | 24.1 n (9.2) | 23.6 n (9.8) | 0.69 |
| Asthma control | ||||
| Well controlled | 21 (10.3%) | 8 (7.6%) | 13 (13.3%) | 0.30 |
| Not well controlled | 100 (49.3%) | 56 (53.3%) | 44 (44.9%) | |
| Very poorly controlled | 82 (40.4%) | 41 (39.0%) | 41 (41.8%) | |
| SHS Exposure + | 116 (61.1%) | 59 (60.8%) | 57 (61.3%) | 0.95 |
| Cotinine level mean (SD) | 2.83 (4.0) | 2.71 (3.9) | 2.97 (4.1) | 0.66 |
| Mice seen in home | 56 (28.9%) | 28 (27.7%) | 28 (30.1%) | 0.71 |
| Cockroaches seen in home | 59 (30.3%) | 30 (29.4%) | 29 (31.2%) | 0.79 |
| Asthma medication fills over 12 months | ||||
| Median controllers Rx {IQR} (post year) | 3 [1–8] | 4 [1–9] | 2.5 [0–7] | 0.02 |
| SABA >4 fills (post year) | 71 (34.8%) | 38 (35.8%) | 33 (33.7%) | 0.74 |
| AMR >0.50 (post year) | 108 (60.3%) | 60 (63.2%) | 48 (57.1%) | 0.41 |
| Worried about medication side effects (@12 mos.) | 60 (30.6%) | 28 (27.7%) | 32 (33.7%) | 0.37 |
N = 204 with complete follow-up data.
a
P-value based on GLM with Poisson distribution specified for count data in evaluation of Symptom free days and nights, Chi-square test to assess distributional between group difference for categorical factors, and Mann-Whitney U test for distributional difference in controller fills.